[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370524-105":3,"doc-detail-370524-en":81,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-effect-of-continuous-infusion-chemotherapy-through-femoral-artery-catheterization-on-gp73-afp-l3-and-safety-efficacy-in-liver-cancer-patients","The effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP-L3, and safety efficacy in liver cancer patients","","This study evaluates how continuous infusion chemotherapy delivered via femoral artery catheterization influences Golgi protein 73 (GP73) and alpha fetoprotein heterogeneity (AFP-L3) in liver cancer patients. A retrospective cohort of 108 patients treated between January 2020 and December 2022 compared transarterial chemoembolization (TACE) with continuous infusion regional arterial chemotherapy via femoral artery catheterization (CIFAC), 54 per group. CIFAC showed lower tumor marker levels after 60 and 90 days, reduced liver injury indicators, fewer adverse reactions, improved quality-of-life scores, and a higher 1-year survival rate.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-effect-of-continuous-infusion-chemotherapy-through-femoral-artery-catheterization-on-gp73-afp-l3-and-safety-efficacy-in-liver-cancer-patients/370524/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-effect-of-continuous-infusion-chemotherapy-through-femoral-artery-catheterization-on-gp73-afp-l3-and-safety-efficacy-in-liver-cancer-patients/370524.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What patient treatments were compared in this study?","Question",{"text":63,"@type":64},"The study compared transarterial chemoembolization (TACE) with continuous infusion regional arterial chemotherapy via femoral artery catheterization (CIFAC). Each group included 54 liver cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biomarkers were used to assess treatment impact?",{"text":68,"@type":64},"The study measured serum tumor markers including GP73, AFP, and AFP-L3, along with related liver function and safety outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"What safety and efficacy differences were observed for CIFAC versus TACE?",{"text":72,"@type":64},"After 60 and 90 days, CIFAC resulted in lower tumor marker levels, improved liver function indicators, fewer adverse reactions, higher Karnofsky scores, and a higher 1-year survival rate.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370524,1790216101,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Clinical and Experimental Medicine (2025) 25:148 [https://doi.org/10.1007/s10238-025-01560-y](https://doi.org/10.1007/s10238-025-01560-y)  \nThe effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP‑L3, and safety efficacy in liver cancer patients  \nQiong Yan1 · Xinguo Sun1 · Yubo Wang2 · Shijiao Duan1 · Bo Wang3  \nReceived: 6 December 2024 / Accepted: 6 January 2025 / Published online: 10 May 2025 © The Author(s) 2025  \nAbstract  \nThis study examines the impact of continuous infusion chemotherapy via femoral artery catheterization on Golgi protein 73 (GP73) and alpha fetoprotein heterogeneity (AFP-L3) in liver cancer patients. A retrospective analysis was conducted on 108 liver cancer patients treated from January 2020 to December 2022, divided into two groups: transarterial chemoembolization (TACE) and continuous infusion regional arterial chemotherapy via femoral artery catheterization (CIFAC), with 54 patients in each group. Serum tumor markers, liver function, adverse reactions, quality of life, and 1-year survival rate were analyzed and compared between the two groups of patients. Prior to treatment, no significant differences were observed in tumor markers, liver function, and quality of life between groups (P>0.05) . After 60 and 90 days, the CIFAC group exhibited significantly lower levels of GP73, AFP, and AFP-L3 compared to TACE (P \u003C 0.05). Additionally, CIFAC patients had lower levels of alanine aminotransferase (ALT), aspartate transaminase (AST), indocyanine green (ICG15) (P \u003C 0.05), reduced adverse reactions (nausea, vomiting, etc.), and higher Karnofsky scores (P\u003C 0.05) . The one-year survival rate of the CIFAC group was significantly higher than that of the TACE group (P \u003C 0.05) . Continuous infusion chemotherapy through femoral artery catheterization can help reduce serum tumor marker levels, improve liver function, and reduce adverse reactions in liver cancer patients.  \nKeywords Liver cancer · Continuous infusion chemotherapy via femoral artery catheterization · Serum tumor markers · Liver function · Adverse reactions  \nIntroduction  \nMalignant tumors have always been a severe threat to the fitness of the Chinese people, among which primary liver cancer (PLC) ranks among the top. PLC mainly includes three types: hepatocellular carcinoma (HCC) [1], intrahepatic cholangiocarcinoma (ICC) [2], and HCC–ICC hybrid type [3] . Among them, HCC accounts for up to 85–90% .  \n* Bo Wang [17707340609@163.com](17707340609@163.com)  \n1 Interventional Catheterization Room, Affiliated Nanhua Hospital, University of South China, Hengyang 421002, China  \n2 Production Department, Guhan Traditional Chinese Medicine Co., Ltd, Hengyang 421000, China  \n3 Physical examination center, Affiliated Nanhua Hospital, University of South China, Hengyang 421002, China  \nChina accounts for 45.3% of the global total PLC cases and 47.1% of liver cancer deaths [4] . There are two main ways to treat PLC: curative treatment and palliative treatment. Radical treatment mainly includes surgical resection of tumors, liver transplantation, and radiofrequency ablation methods [5]. For patients who cannot receive curative treatment, palliative treatment becomes another option [6]. Among many palliative treatment methods, the treatment application of transarterial chemoembolization (TACE) [7] and the continuous infusion regional arterial chemotherapy via femoral artery catheterization (CIFAC) [8] is the most extensive. Early symptoms are not obvious, causing many patients to miss the opportunity for surgery when they experience obvious discomfort and seek medical attention, thus losing the opportunity to receive curative treatment. This has also become the biggest challenge in improving the prognosis of PLC patients [9] .  \nTACE is a commonly used local treatment method for liver cancer. This method mainly involves inserting a  \ncatheter into the tumor blood supply artery and then injecting embolic and chemotherapy","cbCaijaYkgGaAqnV","https://ap.wps.com/l/cbCaijaYkgGaAqnV","pdf",883354,10,"English","# Abstract\n# Introduction\n## Background on primary liver cancer and treatment options\n## TACE: local treatment mechanism and drug delivery\n## CIFAC: regional chemotherapy rationale and indications","[{\"question\":\"What patient treatments were compared in this study?\",\"answer\":\"The study compared transarterial chemoembolization (TACE) with continuous infusion regional arterial chemotherapy via femoral artery catheterization (CIFAC). Each group included 54 liver cancer patients.\"},{\"question\":\"Which biomarkers were used to assess treatment impact?\",\"answer\":\"The study measured serum tumor markers including GP73, AFP, and AFP-L3, along with related liver function and safety outcomes.\"},{\"question\":\"What safety and efficacy differences were observed for CIFAC versus TACE?\",\"answer\":\"After 60 and 90 days, CIFAC resulted in lower tumor marker levels, improved liver function indicators, fewer adverse reactions, higher Karnofsky scores, and a higher 1-year survival rate.\"}]","The effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP-L3, and safety efficacy in liver cancer patients | PDF",1790188958,25,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcfe5b0bca0c04f71ab1e161dc891245.webp",983,1305,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfe633e1535994def2fdb4418ddbbe1f.webp",982,1304,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0e549a4fb9943a5c4dbb34585ee4c1d.webp",981,1303,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4cb5731f2387eed354b7433a06b08fa.webp",980,1301,{"code":4,"msg":82,"data":116},[117,121,125,129,134,139,144,147,152,155,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":91,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":91,"slug":157},"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":130,"slug":161},19,"General","general"]